Induction Healthcare Group PLC (INHC) - Net Assets
Based on the latest financial reports, Induction Healthcare Group PLC (INHC) has net assets worth GBX18.19 Million GBX (≈ $2.21K USD) as of September 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX27.09 Million ≈ $3.30K USD) and total liabilities (GBX8.90 Million ≈ $1.08K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INHC financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX18.19 Million |
| % of Total Assets | 67.14% |
| Annual Growth Rate | N/A |
| 5-Year Change | 63.73% |
| 10-Year Change | N/A |
| Growth Volatility | 76.5 |
Induction Healthcare Group PLC - Net Assets Trend (2019–2024)
This chart illustrates how Induction Healthcare Group PLC's net assets have evolved over time, based on quarterly financial data. Also explore Induction Healthcare Group PLC total assets for the complete picture of this company's asset base.
Annual Net Assets for Induction Healthcare Group PLC (2019–2024)
The table below shows the annual net assets of Induction Healthcare Group PLC from 2019 to 2024. For live valuation and market cap data, see INHC stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | GBX20.38 Million ≈ $2.48K |
-16.12% |
| 2023-03-31 | GBX24.30 Million ≈ $2.96K |
-42.51% |
| 2022-03-31 | GBX42.26 Million ≈ $5.14K |
+156.67% |
| 2021-03-31 | GBX16.47 Million ≈ $2.00K |
+32.29% |
| 2020-03-31 | GBX12.45 Million ≈ $1.51K |
+571.12% |
| 2019-03-31 | GBX-2.64 Million ≈ $-321.45 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Induction Healthcare Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4002300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX469.00K | 2.30% |
| Other Comprehensive Income | GBX460.00K | 2.26% |
| Other Components | GBX62.18 Million | 305.11% |
| Total Equity | GBX20.38 Million | 100.00% |
Induction Healthcare Group PLC Competitors by Market Cap
The table below lists competitors of Induction Healthcare Group PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lipella Pharmaceuticals Inc. Common Stock
NASDAQ:LIPO
|
$111.36K |
|
LIFT GLOBAL VENT. LS-01
F:7XO
|
$111.90K |
|
Celadon Pharmaceuticals PLC
LSE:CEL
|
$112.25K |
|
Croma Security Solutions Group Plc
LSE:CSSG
|
$113.08K |
|
Mobilityone Ltd
LSE:MBO
|
$109.93K |
|
Ceps PLC
LSE:CEPS
|
$109.87K |
|
One Media iP Group Plc
LSE:OMIP
|
$109.61K |
|
Wescoal Holdings Ltd
JSE:SLG
|
$109.06K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Induction Healthcare Group PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 24,296,000 to 20,380,000, a change of -3,916,000 (-16.1%).
- Net loss of 3,257,000 reduced equity.
- New share issuances of 7,000 increased equity.
- Other comprehensive income decreased equity by 956,000.
- Other factors increased equity by 290,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-3.26 Million | -15.98% |
| Share Issuances | GBX7.00K | +0.03% |
| Other Comprehensive Income | GBX-956.00K | -4.69% |
| Other Changes | GBX290.00K | +1.42% |
| Total Change | GBX- | -16.12% |
Book Value vs Market Value Analysis
This analysis compares Induction Healthcare Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 44.39x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | GBX-0.21 | GBX9.75 | x |
| 2020-03-31 | GBX0.98 | GBX9.75 | x |
| 2021-03-31 | GBX0.41 | GBX9.75 | x |
| 2022-03-31 | GBX0.51 | GBX9.75 | x |
| 2023-03-31 | GBX0.26 | GBX9.75 | x |
| 2024-03-31 | GBX0.22 | GBX9.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Induction Healthcare Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -15.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.86%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.64x
- Recent ROE (-15.98%) is above the historical average (-30.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | GBX-2.44 Million |
| 2020 | -28.34% | -2383.11% | 0.01x | 1.20x | GBX-4.77 Million |
| 2021 | -46.24% | -559.44% | 0.07x | 1.22x | GBX-9.26 Million |
| 2022 | -19.95% | -116.61% | 0.13x | 1.31x | GBX-12.66 Million |
| 2023 | -71.55% | -134.92% | 0.34x | 1.58x | GBX-19.81 Million |
| 2024 | -15.98% | -23.86% | 0.41x | 1.64x | GBX-5.29 Million |
Industry Comparison
This section compares Induction Healthcare Group PLC's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $32,546,863
- Average return on equity (ROE) among peers: -19.79%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Induction Healthcare Group PLC (INHC) | GBX18.19 Million | 0.00% | 0.49x | $111.33K |
| Cambridge Cognition Holdings Plc (COG) | $3.36 Million | -53.09% | 2.88x | $201.09K |
| Craneware Plc (CRW) | $32.41 Million | 18.56% | 0.77x | $6.59 Million |
| Diaceutics PLC (DXRX) | $1.01 Million | 73.81% | 2.40x | $1.70 Million |
| Feedback PLC (FDBK) | $1.20 Million | -39.29% | 0.61x | $51.98K |
| IQ-AI Ltd (IQAI) | $590.00K | -47.63% | 0.17x | $24.76K |
| Kooth plc (KOO) | $10.52 Million | -6.81% | 0.53x | $563.19K |
| Optima Health plc (OPT) | $168.12 Million | 0.98% | 0.30x | $2.04 Million |
| Renalytix AI plc (RENX) | $43.17 Million | -104.88% | 0.47x | $95.71K |
About Induction Healthcare Group PLC
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom. The company offers Zesty, a patient engagement platform that provides smart appointment management, paperless letters, targeted questionnaires, and patient information; and Attend Anywhere for video consultations. It also offers registration, messaging, integration, and analytics and reporting plat… Read more